Login / Signup

Cannabis-based product use in a multiple sclerosis cohort.

Alice SchabasV VukojevicC TaylorZ ThuA BadyalJ K ChanV DevonshireA TraboulseeA L SayaoR Carruthers
Published in: Multiple sclerosis journal - experimental, translational and clinical (2019)
CBP use is common based on volunteer reporting, with approximately one out of four patients who attend the UBCH MS clinic using CBPs.
Keyphrases
  • multiple sclerosis
  • primary care
  • adverse drug
  • white matter
  • mass spectrometry
  • ms ms
  • emergency department